SCI Pharmtech, Inc. (TPE:4119)
Taiwan · Delayed Price · Currency is TWD 48.55
-1.45 (-2.90%)
Apr 17, 2026, 1:30 PM CST
SCI Pharmtech Market Cap
SCI Pharmtech has a market cap or net worth of 5.8 billion as of April 17, 2026. Its market cap has decreased by -41.58% in one year.
Market Cap
5.80B
Enterprise Value
6.71B
Revenue
1.34B
Ranking
n/a
PE Ratio
54.04
Stock Price
48.55
Market Cap Chart
Since January 5, 2004, SCI Pharmtech's market cap has increased from 1.06B to 5.80B, an increase of 444.93%. That is a compound annual growth rate of 7.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 5.80B | -0.31% |
| Dec 31, 2025 | 5.82B | -46.25% |
| Dec 31, 2024 | 10.83B | -6.40% |
| Dec 29, 2023 | 11.57B | 24.39% |
| Dec 30, 2022 | 9.30B | 16.07% |
| Dec 30, 2021 | 8.01B | 20.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.07B |
| Standard Chemical & Pharmaceutical | 11.26B |
| Alar Pharmaceuticals | 11.22B |
| Formosa Laboratories | 6.34B |
| LIWANLI Innovation | 6.11B |
| Orient Pharma | 5.75B |
| Easywell Biomedicals | 5.42B |
| Orient EuroPharma | 4.11B |